2019
DOI: 10.1016/j.poly.2019.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, crystal structures and cytotoxic activity of two zinc(II) complexes derived from benzimidazole derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 34 publications
1
10
0
Order By: Relevance
“…Components with a series of concentration (62.5, 125, 250 and 500 μL/mL) and positive control at the concentrations (25, 50 and 100 μL/mL) were added and incubated for 48 h. After incubation using cell counting Kit-8 (CCK-8), a non-radioactive colorimetric Cell Proliferation and Cytotoxicity assay kit (Sigma-Aldrich, USA) was used for measuring cell viability. Duplicate wells were used for each sample [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…Components with a series of concentration (62.5, 125, 250 and 500 μL/mL) and positive control at the concentrations (25, 50 and 100 μL/mL) were added and incubated for 48 h. After incubation using cell counting Kit-8 (CCK-8), a non-radioactive colorimetric Cell Proliferation and Cytotoxicity assay kit (Sigma-Aldrich, USA) was used for measuring cell viability. Duplicate wells were used for each sample [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…A copper (II) complex ( 276 ) of benzimidazole derivatives showed excellent potency at 72 h post treatment against prostate cancer cell line (DU145) with IC 50 10 µM ( Kacar et al, 2020 ). Besides, two zinc (II) complexes with 2-[2-(benzimidazol-2-yl)-phenyl]-1-methyl-benzimidazole and 1,2-bis(1-methyl-benzimidazol-2-yl)-benzene exerted both dose and time dependent cytotoxicity against breast cancer cell lines (MB-MDA-231) ( Su et al, 2019 ). In another study ( Yılmaz et al, 2019 ), 18 complexes of zinc (II) and cobalt (II) containing 1-benzyl and 2-phenyl moieties showed in vitro potency against human prostate (DU-145) and human ovarian (A-2780) cancer cell lines.…”
Section: Biological Activitiesmentioning
confidence: 99%
“…The free ligands and the related complexes exhibited lower cytotoxic activities compared to the reference drug cisplatin (IC 50 = 9.92 µM). The better cytotoxicity of complex 30b (IC 50 = 38.65 µM) compared to that of complex 30a (IC 50 > 50 µM) could be related to its higher lipophilicity (log p values for complexes 30a and 30b are 0.74 and 1.84, respectively) [ 171 ].…”
Section: Imidazoles and Analogous Imidazole-based Systemsmentioning
confidence: 99%